FBXW7 and lung carcinoma: Furthermore, treatment with decitabine, in vitro lung cancer cells, and in vivo lung cancer xenograft mouse models reverted the FBXW7 promoter to a non-methylated state, resulting in increased expression of FBXW7 (DiNardo et al., 2018).